<table width="70%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2: Clinically Significant Drug Interactions with STARLIX</caption>
<col width="35%"></col>
<col width="65%"></col>
<tbody>
<tr>
<td colspan="2" stylecode="Toprule Lrule Rrule">
<content stylecode="bold">Drugs That May Increase the Blood-Glucose-Lowering Effect of STARLIX and Susceptibility to Hypoglycemia</content>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule">
<content stylecode="italics">Drugs:</content>
</td>
<td stylecode="Toprule Rrule">Nonsteroidal anti-inflammatory drugs (NSAIDs), salicylates, monoamine oxidase inhibitors, non-selective beta-adrenergic-blocking agents, anabolic hormones (e.g. methandrostenolone), guanethidine, gymnema sylvestre, glucomannan, thioctic acid, and inhibitors of CYP2C9 (e.g. amiodarone, fluconazole, voriconazole, sulfinpyrazone), alcohol.</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Toprule Rrule">Dose reductions and increased frequency of glucose monitoring may be required when STARLIX is coadministered with these drugs.</td>
</tr>
<tr>
<td colspan="2" stylecode="Toprule Lrule Rrule">
<content stylecode="bold">Drugs and Herbals That May Reduce the Blood-Glucose-Lowering Effect of STARLIX and Increase Susceptibility to Hyperglycemia</content>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule">
<content stylecode="italics">Drugs:</content>
</td>
<td stylecode="Toprule Rrule">Thiazides, corticosteroids, thyroid products, sympathomimetics, somatropin, somatostatin analogues (e.g. lanreotide, octreotide), and CYP inducers (e.g. rifampin, phenytoin and St Johnâ€™s Wort).</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Toprule Rrule">Dose increases and increased frequency of glucose monitoring may be required when STARLIX is coadministered with these drugs.</td>
</tr>
<tr>
<td colspan="2" stylecode="Toprule Lrule Rrule">
<content stylecode="bold">Drugs That May Blunt Signs and Symptoms of Hypoglycemia</content>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule">
<content stylecode="italics">Drugs:</content>
</td>
<td stylecode="Toprule Rrule">beta-blockers, clonidine, guanethidine, and reserpine</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Toprule Rrule">Increased frequency of glucose monitoring may be required when STARLIX is coadministered with these drugs.</td>
</tr>
</tbody>
</table>